Magnetar Financial’s Pfizer PFE Stock Holding History

Magnetar Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,054,000	Closed	-$8.55M	–	549
2020 Q1	$8.55M	Buy	+1,054,000	New	+$35.9M	0.21%	97
2019 Q3	–	Sell	-79,050	Closed	-$22K	–	559
2019 Q2	$22K	Buy	+79,050	New	+$3.14M	﹤0.01%	435
2015 Q2	–	Sell	-316,200	Closed	-$10.4M	–	456
2015 Q1	$10.4M	Buy	+316,200	New	+$10.1M	0.18%	96
2013 Q3	–	Sell	-3,152,092	Closed	-$83.8M	–	513
2013 Q2	$83.8M	Buy	+3,152,092	New	+$87.1M	1.83%	11

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Magnetar Financial's PFE Position: Q2 2025 in Review

Magnetar Financial sold out of Pfizer (PFE) in Q2 2025, closing a stake of 71,927 shares — an estimated $1.82M sold.

Magnetar Financial first reported a position in PFE in Q2 2013 and held it in 30 quarters. The position peaked at $83.8M in Q2 2013. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Magnetar Financial reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Magnetar Financial sold 71,927 Pfizer shares in Q2 2025, an estimated $1.82M.
Magnetar Financial first reported a position in Pfizer in Q2 2013 and held it in 30 quarters.
Magnetar Financial's Pfizer position peaked at $83.8M in Q2 2013.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Magnetar Financial's 13F filing for Q2 2025, filed 12 Aug 2025.